Strateos offers a wide range of off the shelf drug discovery assays and supports custom development of biochemical, biophysical and cell based assays in drug discovery, using both industry-standard and innovative technologies to support drug screening projects from hit identification to lead optimization.

We also have broad experience in a variety of target classes ranging from GPCRs, kinases, ion channels, nuclear receptors, proteases and protein-protein interactions in many therapeutic areas. Our highly experienced team can also provide project strategy, design, and implementation guidance throughout the drug discovery assay development process.